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Background and aims: Hearing loss (HL) is the most common sensorineural disorder affecting 1 in 1000 newborns. Autosomal recessive 
non-syndromic hearing loss (ARNSHL), which is the most common cause of severe HL, is caused by mutations in more than 80 loci. 
The OTOA gene located on DFNB22 is a rare cause of the disease and the gene studied less in Iranian ARNSHL families. Hence, limited 
information is available on the frequency and type of OTOA mutations in different populations. In this study, we investigated the role of 
DFNB22 locus in ARNSHL patients in Khuzestan province, Iran.
Materials and Methods: In this descriptive-experimental study, 23 large families with pre-lingual ARNSHL from Khuzestan province were 
enrolled. Mutations in GJB2 were excluded by DNA sequencing followed by linkage analysis. Homozygosity mapping of DFNB22 was 
conducted using 6 short tandem repeat polymorphic markers via touch-down PCR and polyacrylamide gel electrophoresis. Homozygosity-
by-descent was identified by calculating two-point and multi-point LOD score and haplotype reconstruction. 
Results: Families were negative for GJB2 mutations. Genotyping the STRP markers, haplotype reconstruction, and two-point and multiple-
point LOD scores did not show homozygosity-by-descent in any of the pedigrees. 
Conclusion: Our findings suggest that OTOA mutations might not contribute significantly to the molecular pathophysiology of ARNSHL in 
Khuzestan province. However, extending the sample size can illuminate the role of this gene in Khuzestan province.
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Introduction 
Hearing loss (HL) is the most common sensorineural 
disorder with more than 400 million people affected 
worldwide. According to the epidemiological studies, 
1 per 1000 infants suffers from severe to profound HL 
(1). Communication and language difficulties are the 
consequences of a delayed diagnosis (2).
HL could occur due to genetic and environmental factors 
or a combination of both. It is estimated that 50% of the 
patients are genetically defective. Non-syndromic HL 
includes more than 70% of the cases, while the syndromic 
form is a rare condition which comprises about 30% of 
the patients (3). Autosomal recessive non-syndromic HL 
(ARNSHL) is the most common form of hereditary HL 
(1,4). To date, about 90 distinct loci and 60 genes have 
been identified for ARNSHL as a highly heterogeneous 
condition (5).
The high rate of consanguinity increases the incidence 
of recessive genetic disorders. Hence, Iran with an average 
rate of 38.6% includes families with rare conditions in 
comparison with other parts of the world (6). HL accounts 
for the second most common cause of disability in Iran.
Mutations in the GJB2 and GJB6 genes, located on 
DFNB1A/B, have been targeted in most studies in 
Iran. The prevalence of GJB2 mutations varies among 
different Iranian ethnicities, with the highest frequency 
of mutations in the northern regions of Iran and the 
absence of mutations in southern provinces like Sistan and 
Baluchestan (7). Elucidating the role of other DFNB loci 
in each of ethnic populations of Iran could give us a better 
insight for genetic diagnosis of ARNSHL in the future. 
Genetic linkage analysis is a powerful method to 
investigate genetically heterogeneous diseases in large 
families. The method is based on autozygosity mapping, 
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which was first proposed by Botstein and Lander (8). 
The OTOA gene is located on DFNB22 locus and 
contains 28 exons and encompasses 82.2 kb region of 
the genome. The OTOA gene produces the otoancorin 
with 1140 amino acids. This protein is mainly expressed 
on the apical surfaces of the polar epithelial cells located 
within the inner ear and has no similarity to non-collagen 
glycoproteins of acellular gels in the inner ear. It appears 
that this protein is involved in the attachment of acellular 
gels to the sensory and non-sensory cells of the inner ear 
(9).
About 17 pathogenic variants have been identified in 
previous studies throughout the world (10). Hence, limited 
information is available on the frequency and type of 
mutations in the OTOA gene in different populations. Here 
we aimed to investigate the role of DFNB22 in molecular 
pathology of ARNSHL in the GJB2-negative families.
Materials and Methods
Subjects and sampling
The present descriptive-experimental study was conducted 
in Cellular and Molecular Research Center of Shahrekord 
University of Medical Sciences. The study was conducted 
on 23 large inbred families with about 120 ARNSHL 
individuals recruited from Khuzestan province. Clinical 
investigations including skeletal, eye, kidney, heart, and 
cutaneous examination were performed. MRI and CT 
scan were conducted to detect inner ear malformations. 
Deafness severity was proved by pure-tone audiometry at 
frequencies ranging from 250 Hz to 8000 Hz.
Genomic DNA extraction
After obtaining informed written consent from patients 
or their parents, 5 mL of peripheral blood was collected 
in EDTA-containing tubes. DNA was extracted by the 
phenol-chloroform method and its quantity and quality 
were measured via Nanospec cube biophotometer 
(Nanolytik®, Dusseldorf, Germany) and 1% agarose gel 
electrophoresis (11).
The mutation analysis GJB2 gene 
At least, one patient from each family underwent mutation 
analysis of the GJB2 gene through PCR-sequencing using 
forward: 5'-CTCCCTGTTCTGTCCTAGC-3' and 
reverse: 5'-CTCATCCCTCTCATGCTGTC-3' primers. 
In addition, genetic linkage analysis of DFNB1A/B was 
performed by short tandem repeat polymorphic (STRP) 
markers to rule out regulatory and non-coding mutations 
of the GJB2 gene and mutations of the GJB6 gene.
 
Genetic linkage analysis of the OTOA gene
Simulation analysis was performed using FastSLink software 
version 2.51 to evaluate suitable families for genetic linkage 
analysis. Six STRP markers were selected via NCBI Genome 
Browser and UCSC Map Viewer databases. The criteria for 
selecting markers were the distance from the gene and their 
polymorphic content. In the case of uninformative markers, 
other markers close to the gene were replaced. The primers 
were designed by primer3 version 0.4.0 (http://bioinfo.
ut.ee/primer3-0.4.0/) and primer specificity was checked 
by NCBI primer blast. Touch-down polymerase chain 
reaction (PCR) was applied under standard condition to 
amplify STRP markers. Primer sequences are presented in 
Table 1. 
Each microtube for PCR contained 2.5 μL of PCR buffer 
(10X), 0.5 μL of MgCL2 (50 mM), 0.5 μL of dNTP (10 
mM), 0.5 μL of each primer (10 pM), 1 μL of DNA (40–50 
ng), and 0.1 μL of Taq polymerase, and distilled water was 
added to reach a final volume of 25 μL. Standard cycling 
conditions were performed in a thermocycler (ASTEC 
PC-818; ASTEC, Fukuka, Japan). The touch-down PCR 
program was as follows: the initial denaturation at 95ºC 
for 3 minutes, 8 cycles of 95ºC for 30 seconds, 60ºC for 
30 seconds in the first cycle with 1ºC reduction per cycle, 
and 72ºC for 25 seconds, 27 cycles of 95ºC for 30 seconds, 
Figure 1. The LOD scores of the families.
Note. The horizontal axis represents the families and the vertical 
axis represents the SLINK value.
Table 1. Markers used for DFNB22 locus and Their Primers
Name Forward primer Reverse primer Product size (bp)
D16S3045 ATGTAGNACGGCTGAATGTC GGCCAGATCACATAGTCTCA 220-247
D16S3046 CCCAGAATAAACTGCGTG TTCATGGACCCCCTATTG 84-108
D16S403 GTCACCAGATTGCATGTTTT TATTCATTTGTGTGGGCATG 134-152
D16S3099 GAGTAGCATCTCACAACATCTCAC ACTTTACCCTTAGGGCTCTCC 167-177
D16S417 TCCTTCTTCCCATAACAACA GGATAATGAGTCTCTCTTTCCC 124-144
D16S3041 AGTCCCTGCCTTGGTTAGTT CAGCCTAGGTGACAGAGAAA 244-274
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role in the incidence of HL. The GJB2 gene, which has 
contributed to 16-18% of ARNSHL in Iran, is known 
to be the first cause of the disease throughout the world 
(13,14). Subsequently, SLC26A4 located on DFNB4 
(accounting for about 10%) and TECTA located on 
DFNB21 (accounting for approximately 4%) are the most 
common genes involved in ARNSHL in Iran (12). 
A significant percentage of disease-causing genes remain 
unknown, suggesting the need for further genomic studies 
to uncover the disease etiology. 
In this study, we examined the contribution of DFNB22 
in 23 families with at least three deaf members in Khuzestan 
province in order to complete the studies on ARNSHL. 
The first study on this locus was conducted in 2002 by 
Zwaenepoel et al on 200 large Palestinian consanguineous 
families, which led to identification of DFNB22 in 
16p13.1-q11.2 chromosome region carrying the OTOA 
gene. The IVS12+2T-C mutation in splice site of this gene 
was identified in one of the families (15).
In another study, Shahin et al in 2010 identified a 
homozygous 500 kb deletion that resulted in complete 
deletion of this gene. In the three Pakistani families, 
two different heterozygous substitution mutations 
(G451D, P627S) were identified in this gene. Although 
no functional studies have been carried out to investigate 
the effect of these two mutations, it is presumed that both 
would lead to a disruption of the super-helical structure of 
the otoancorin (16). Another Pakistani family showed two 
transient mutations causing disease: c.1352G>A in exon 13 
and c.1879C>T in exon 17 (17).
Investigating 300 families with Chinese, Caucasian, 
Israeli, and Spanish origins in separate studies showed no 
linkage to this locus (18,19). 
Figure 3. Haplotypes represent lack of genetic linkage in one of the 
studied families. In this pedigree, in patients with different allelic 
haplotypes, there is no association between HL and this locus in 
this family. The genetic map of the markers is based on Marshfield.
Figure 2. The D16S3045 marker. 
Note. Columns represent the genotype of an example family, 1: 
ladder 100 bp, 2: father, 3: mother, 4, 5: HL offspring, 6: healthy 
offspring. This marker showed homozygous pattern only in one of 
the deaf children, although the other was heterozygous.
53ºC for 30 seconds, 72ºC for 25 seconds and one cycle of 
the final extension at 72ºC for 10 minutes.
PCR products were resolved on a non-denaturing 8-12% 
polyacrylamide gel and stained by silver nitrate. Genotyping 
was done by visual inspection. Haplotype reconstruction 
was carried out by HaploPainter version 1.043 (12).
The two-point and multipoint parametric LOD scores 
were computed respectively by SuperLink version 1.6 and 
SimWalk version 2.91. The haplotype map was plotted 
using the HaploPainter software version 1.043 to confirm 
or reject homozygosity.
Results
The current study investigated 23 DFNB1A/B-negative 
families. Pedigree analysis and clinical examination 
outcomes suggested the presence of ARNSHL. The 
majority of deaf individuals suffered from severe to 
profound bilateral sensorineural HL. The values of the 
LOD scores of the families were estimated to be 1.5-7 
(Figure 1).
The mutation analysis of GJB2 and homozygosity 
mapping of DFNB1A/B revealed no mutation or disease 
association. STRP genotyping and haplotyping were 
repeated at least twice for each family. Haplotype analysis 
and LOD scores did not show homozygosity-by-descent at 
DFNB22 in any of the families (Figure 2). An example of 
the plotted haplotype is shown in Figure 3. 
 
Discussion
HL is a genetically heterogeneous disorder. It is estimated 
that up to 1% of human genes are involved in auditory 
processing (5). However, in most studies, researchers 
investigated the most prevalent genes and determined their 
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No mutation in this gene has been reported in Iran until 
now. In a study on 41 large families with HL, no family 
showed linkage to this locus (20).
Another study on 67 families from different provinces 
of Iran reported no linkage to this locus (21). Further, a 
survey on 144 families from different Iranian populations 
revealed no mutation in this locus (22).
In the present study, considering the fact that we 
investigated 23 large families with high consanguinity 
rates, there was no linkage to this locus, confirming other 
studies in Iran, all of which relate to the insignificant role of 
this locus in the incidence of HL. The cause of HL in these 
patients is likely to be loci involved with a higher incidence.
To determine the role of this locus in developing HL, it is 
necessary to extend studies to other areas and families in 
order to examine its role more precisely.
Conclusion
According to the results obtained from the present study, 
it is likely that this locus has a minor role in the incidence 
of HL in the studied population. However, in order to 
determine the precise contribution of loci involved in HL 
in Iran, further studies are required on the role of DFNB22 
and other loci in developing HL to find an approach for 
diagnosis, genetic counseling, and prevention.
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